Obesity, type 2 diabetes, and cardiovascular diseases share a common metabolic environment characterized by insulin resistance [68]; therefore, regulating insulin resistance and secretion could be a key mechanism to prevent the aggravation of obesity and its related metabolic diseases. This evidence concerns the gene INS and metabolic disease.